BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15451176)

  • 1. Inactivation of adenovirus types 5 and 6 by Virkon S.
    McCormick L; Maheshwari G
    Antiviral Res; 2004 Oct; 64(1):27-33. PubMed ID: 15451176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of in-vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines.
    Herńndez A; Martró E; Matas L; Martín M; Ausina V
    J Hosp Infect; 2000 Nov; 46(3):203-9. PubMed ID: 11073729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal inactivation of adenovirus type 5.
    Maheshwari G; Jannat R; McCormick L; Hsu D
    J Virol Methods; 2004 Jun; 118(2):141-6. PubMed ID: 15081609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart Card Decontamination in a High-Containment Laboratory.
    Gabbert LR; Smith JD; Neilan JG; Ferman GS; Rasmussen MV
    Health Secur; 2018; 16(4):244-251. PubMed ID: 30096256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the antiviral activity of the disinfectant VIRKON].
    Bonfanti C; Pollara P; De Rango C; Turano A
    Ann Ig; 1995; 7(1):55-62. PubMed ID: 8663967
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of Virkon S fogging on survival of Salmonella enterica and Staphylococcus aureus on surfaces in a veterinary teaching hospital.
    Dunowska M; Morley PS; Hyatt DR
    Vet Microbiol; 2005 Feb; 105(3-4):281-9. PubMed ID: 15708826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virucidal activity of Virkon S on human enterovirus.
    Chan YF; Abu Bakar S
    Med J Malaysia; 2005 Jun; 60(2):246-8. PubMed ID: 16114171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculocidal activity of a peroxymonosulphate-based disinfectant-detergent (Virkon).
    De Lorenzi S; Finzi G; Mosca B; Salvatorelli G
    J Hosp Infect; 2008 Jan; 68(1):96-7. PubMed ID: 18069085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the disinfectant activity of the compound VIRKON].
    Ricci A; Carnuccio V; Suzzi R; Pascali A; Gasponi A; Bolognesi V; Bolognesi E
    Ann Ig; 1995; 7(1):27-33. PubMed ID: 8663961
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial effectiveness of 2% glutaraldehyde versus other disinfectants for hospital equipment, in an in vitro test based on germ-carriers with a high microbial contamination.
    Herruzo-Cabrera R; Uriarte MC; Rey-Calero J
    Rev Stomatol Chir Maxillofac; 1999 Dec; 100(6):299-305. PubMed ID: 10672649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Germicidal activity of the detergent VIRKON].
    Braga A
    Ann Ig; 1995; 7(1):35-41. PubMed ID: 8663963
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of infectious bursal disease and Newcastle disease viruses at temperatures below 0 C using chemical disinfectants.
    Guan J; Chan M; Brooks BW; Rohonczy L
    Avian Dis; 2014 Jun; 58(2):249-54. PubMed ID: 25055629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the bactericidal activity of a new disinfectant (Virkon)].
    Clerici P; Decé F; Pescatori T; Pagani N
    Ann Ig; 1992; 4(2):113-7. PubMed ID: 1283942
    [No Abstract]   [Full Text] [Related]  

  • 14. The action of VIRKON No Foam on the hepatitis B virus.
    Scioli D; Pizzella T; Vollaro L; Nardiello S; De Feo L
    Eur J Epidemiol; 1997 Dec; 13(8):879-83. PubMed ID: 9476816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sporicidal activity of VIRKON].
    Delia S
    Ann Ig; 1995; 7(1):43-7. PubMed ID: 8663964
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of fungicidal efficacy of benzalkonium chloride (Steramina G u.v.) and Virkon-S against Microsporum canis for environmental disinfection.
    Marchetti V; Mancianti F; Cardini G; Luchetti E
    Vet Res Commun; 2006 Apr; 30(3):255-61. PubMed ID: 16437301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of mycobactericidal activity of the disinfectant VIRKON by polymerase chain reaction (PCR)].
    Vollaro L; Scioli C
    Ann Ig; 1995; 7(1):49-53. PubMed ID: 8663965
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimycobacterial activity of 'Virkon'.
    Broadley SJ; Furr JR; Jenkins PA; Russell AD
    J Hosp Infect; 1993 Mar; 23(3):189-97. PubMed ID: 8099093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of in vitro efficacy of the disinfectant Virkon.
    Gasparini R; Pozzi T; Magnelli R; Fatighenti D; Giotti E; Poliseno G; Pratelli M; Severini R; Bonanni P; De Feo L
    Eur J Epidemiol; 1995 Apr; 11(2):193-7. PubMed ID: 7672075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of glutaraldehyde and peroxygen for disinfection of dental instruments.
    Angelillo IF; Bianco A; Nobile CG; Pavia M
    Lett Appl Microbiol; 1998 Nov; 27(5):292-6. PubMed ID: 9830148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.